Huaping Yang
Papers
1
Total Citations
24
H-Index
1
About
Dr. Huaping Yang is a leading thoracic surgeon and researcher whose work centers on advancing surgical oncology for lung cancer, particularly through the integration of robotic-assisted techniques and immunotherapy. His major contributions lie in evaluating the feasibility and safety of robotic-assisted thoracic surgery (RATS) for patients with stage III non-small cell lung cancer (NSCLC), a notoriously heterogeneous and challenging disease with poor prognosis. In a landmark 2022 real-world prospective cohort study (24 citations), Dr. Yang demonstrated that RATS following neoadjuvant chemoimmunotherapy is a viable, safe approach, offering new hope for this complex patient population. His research bridges the gap between cutting-edge immunotherapy and minimally invasive surgery, directly addressing a critical clinical debate on optimal management strategies. With a growing citation impact, Dr. Yang’s work is shaping evidence-based protocols that prioritize both oncologic efficacy and postoperative recovery. His dedication to translating novel multimodal treatments into practical, patient-centered outcomes marks him as a pivotal figure in the evolution of lung cancer care.
Research Focus
Key Achievements
Top Papers
- 1